Evolus Inc (EOLS)
12.76
+0.16
(+1.23%)
USD |
NASDAQ |
May 14, 16:00
12.76
0.00 (0.00%)
After-Hours: 16:48
Evolus Gross Profit Margin (Quarterly): 69.55% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 69.55% |
| December 31, 2023 | 68.41% |
| September 30, 2023 | 69.15% |
| June 30, 2023 | 70.19% |
| March 31, 2023 | 70.89% |
| December 31, 2022 | 69.37% |
| September 30, 2022 | 60.21% |
| June 30, 2022 | 57.43% |
| March 31, 2022 | 61.05% |
| December 31, 2021 | 54.31% |
| Date | Value |
|---|---|
| September 30, 2021 | 56.93% |
| June 30, 2021 | 56.69% |
| March 31, 2021 | 59.91% |
| December 31, 2020 | 64.63% |
| September 30, 2020 | 72.52% |
| June 30, 2020 | 75.04% |
| March 31, 2020 | 59.80% |
| December 31, 2019 | 81.30% |
| September 30, 2019 | 71.76% |
| June 30, 2019 | 71.44% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
54.31%
Minimum
Dec 2021
81.30%
Maximum
Dec 2019
66.03%
Average
68.78%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Viatris Inc | 41.05% |
| Shockwave Medical Inc | 87.11% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 74.85% |
| Xtant Medical Holdings Inc | 60.97% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -32.88% |
| Return on Invested Capital | -62.33% |
| Profit Margin (Quarterly) | -22.09% |
| Operating Margin (Quarterly) | -12.38% |
| Return on Net Operating Assets | -47.79% |